Open access
Aug 2026
Discovery and Development of First-in-Class Cereblon-Recruiting RIPK1 Degraders
LD5095 demonstrates potent and selective RIPK1 degradation across cell lines, with rapid kinetics and sustained degradation over 72h post-washout, and exhibited favorable pharmacokinetics, including metabolic stability and an extended half-life.
Dong Lu, Xin Yu, Han-Qing Lin et al.
· Journal of Medicinal Chemist... · 1 citation